Clinical Trial Update: Clinical Trial of Autologous CD19 CAR-T Cells (CNCT19) Therapy for Advanced Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating autologous CD19 CAR-T CNCT19 therapy for advanced hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• CNCT19 (CNCT19 cell therapy)

Snippet

Sponsor: Zhejiang University | Conditions: Advanced Hepatocellular Carcinoma | Phase 1 | Status: RECRUITING